1382981-08-9

Basic information

• Product Name: 2-(2-chloro-6-morpholino-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-8-yl)-1,3-hexadeuterio-propan-2-ol
• CAS NO: 1382981-08-9
• Molecular Weight: 387.815
• Mol File: 1382981-08-9.mol

Chemical Properties

• CAS DataBase Reference: 2-(2-chloro-6-morpholino-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-8-yl)-1,3-hexadeuterio-propan-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-chloro-6-morpholino-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-8-yl)-1,3-hexadeuterio-propan-2-ol(1382981-08-9)
• EPA Substance Registry System: 2-(2-chloro-6-morpholino-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-8-yl)-1,3-hexadeuterio-propan-2-ol(1382981-08-9)

Safety Data

• Hazardous Substances Data: 1382981-08-9(Hazardous Substances Data)

Upstream product

• 666-52-4 [⁽²⁾H₆]acetone 
• 95758-04-6 2-chloro-6-(morpholin-4-yl)-9-(tetrahydro-2H-pyran-2-yl)-9H-purine 

Downstream Products

• 1382981-10-3 2-(2-chloro-6-morpholino-9H-purin-8-yl)-1,3-hexadeuterio-propan-2-ol 

Relevant articles and documents

TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

Tricyclic PI3k inhibitor compounds of Formula I with anti-cancer activity, anti- inflammatory activity, or immunoregulatory properties, and more specifically with PI3 kinase modulating or inhibitory activity are described. Methods are described for using the tricyclic PI3K inhibitor compounds of Formula I for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, organisms, or associated pathological conditions. Formula I compounds include stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof. The dashed lines indicate an optional double bond, and at least one dashed line is a double bond. The substituents are as described.